semaglutide indication FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

T/T individuals who maintain adequate 5-MTHF (active folate) through supplementation and dietary sources have substantially better SAM availability and presumably better epigenetic age outcomes than T/T individuals with poor folate status

It still helps with weight and blood sugar but has only one hormone pathway

Chronic dry mouth can actually improve sublingual absorption in some cases because the medication is not immediately diluted by excess saliva

The course recommended is matched to the size and number of areas at your free consultation, and the full price is confirmed in writing before the first session is booked